|
1
|
Tachimori Y, Ozawa S, Numasaki H,
Fujishiro M, Matsubara H, Oyama T, Shinoda M, Toh Y, Udagawa H, Uno
T, et al: Comprehensive regitry of esophageal cancer in Japan,
2009. Esophagus. 13:110–137. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kikuchi A, Yamamoto H and Sato A:
Selective activation mechanisms of Wnt signaling pathways. Trends
Cell Biol. 19:119–129. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Duchartre Y, Kim YM and Kahn M: The Wnt
signaling pathway in cancer. Crit Rev Oncol Hematol. 99:141–149.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Behrens J, von Kries JP, Kühl M, Brihn L,
Wedlich D, Grosschedl R and Birchmeier W: Functional interaction of
beta-catenin with the transcription factor LEF-1. Nature.
382:638–642. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Molenaar M, van de Wetering M, Oosterwegel
M, Peterson-Maduro J, Godsave S, Korinek V, Roose J, Destrée O and
Clevers H: XTcf-3 transcription factor mediates
beta-catenin-induced axis formation in Xenopus embryos. Cell.
86:391–399. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nelson WJ and Nusse R: Convergence of Wnt,
beta-catenin, and cadherin pathways. Science. 303:1483–1487. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Firestein R, Bass AJ, Kim SY, Dunn IF,
Silver SJ, Guney I, Freed E, Ligon AH, Vena N, Ogino S, et al: CDK8
is a colorectal cancer oncogene that regulates beta-catenin
activity. Nature. 455:547–551. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fritzmann J, Morkel M, Besser D, Budczies
J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlaq PM and
Birchmeier W: A colorectal cancer expression profile that includes
transforming growth factor beta inhibitor BAMBI predicts metastatic
potential. Gastroenterology. 137:165–175. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Takigawa Y and Brown AM: Wnt signaling in
liver cancer. Curr Drug Targets. 9:1013–1024. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang S, Li J, He F and Wang XM: Abnormal
nuclear expression of Pygopus-2 in human primary hepatocellular
carcinoma correlates with a poor prognosis. Histopathology.
67:176–184. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fu L, Zhang C, Zhang LY, Dong SS, Lu LH,
Chen J, Dai Y, Li Y, Kong KL, Kwong DL and Guan XY: Wnt2 secreted
by tumour fibroblasts promotes tumour progression in oesophageal
cancer by activating of the Wnt/β-catenin signaling pathway. Gut.
60:1635–1643. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Verras M, Brown J, Li X, Nusse R and Sun
Z: Wnt3a growth factor induces androgen receptor-mediated
transcription and enhances cell growth in human prostate cancer
cells. Cancer Res. 64:8860–8866. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gao Q, Qin SJ, Fan J, Zhou J, Xiao YS, Xu
Y, Li YW and Tang ZY: Intratumoral balance of regulatory and
cytotoxic T cells is associated with prognosis of hepatocellular
carcinoma after resection. J Clin Oncol. 25:2586–2593. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bisson I and Prowse DM: WNT signaling
regulates self-renewal and differentiation of prostate cancer cells
with stem cell characteristics. Cell Res. 19:683–697. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Makino T, Yamasaki M, Takemasa I, Takeno
A, Nakamura Y, Miyata H, Takiguchi S, Fujiwara Y, Matsuura N, Mori
M and Doki Y: Dickkopf-1 expression as a marker for predicting
clinical outcome in esophageal squamous cell carcinoma. Ann Surg
Oncol. 16:2058–2064. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kaur N, Chettiar S, Rathod S, Rath P,
Muzumdar D, Shaikh ML and Shiras A: Wnt3a mediated activation of
Wnt/β-catenin signaling promotes tumor progression in glioblastoma.
Mol Cell Neurosci. 54:44–57. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
King TD, Suto MJ and Li Y: The
Wnt/β-catenin signaling pathway: A potential therapeutic target in
the treatment of triple negative breast cancer. J Cell Biochem.
113:13–18. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fox SA, Richards AK, Kusumah I, Perumal V,
Bolitho EM, Mutsaers SE and Dharmarajan AM: Expression profile and
function of Wnt signaling mechanisms in malignant mesothelioma
cells. Biochem Biophys Res Commun. 440:82–87. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qi L, Sun B, Liu Z, Cheng R, Li Y and Zhao
X: Wnt3a expression is associated with epithelial-mesenchymal
transition and promotes colon cancer progression. J Exp Clin Cancer
Res. 33:1072014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pan LH, Yao M, Cai Y, Gu JJ, Yang XL, Wang
L and Yao DF: Oncogenic Wnt3a expression as an estimable prognostic
marker for hepatocellular carcinoma. World J Gastroenterol.
22:3829–3836. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Goto M, Mitra RS, Liu M, Lee J, Henson BS,
Carey T, Bradford C, Prince M, Wang CY, Fearon ER and D'Silva NJ:
Rap1 stabilizes beta-catenin and enhances beta-catenin-dependent
transcription and invasion in squamous cell carcinoma of the head
and neck. Clin Cancer Res. 16:65–76. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Deng F, Zhou K, Cui W, Liu D and Ma Y:
Clinicopathological significance of wnt/β-catenin signaling pathway
in esophageal squamous cell carcinoma. Int J Clin Exp Pathol.
8:3045–3053. 2015.PubMed/NCBI
|
|
23
|
Ishiguro H, Wakasugi T, Terashita Y,
Sakamoto N, Tanaka T, Sagawa H, Okubo T and Takeyama H: Nuclear
expression of TCF4/TCF7L2 is correlated with poor prognosis in
patients with esophageal squamous cell carcinoma. Cell Mol Biol
Lett. 21:52016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thiery JP: Epithelial-mesenchymal
transitions in tumor progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Smith BN and Bhowmick NA: Role of EMT in
metastasis and therapy resistance. J Clin Med. 5:E172016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tanaka M, Kijima H, Shimada H, Makuuchi H,
Ozawa S and Inokuchi S: Expression of podoplanin and vimentin is
correlated with prognosis in esophageal squamous cell carcinoma.
Mol Med Rep. 12:4029–4036. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jin H, Morohashi S, Sato F, Kudo Y,
Akasaka H, Tsutsumi S, Ogasawara H, Miyamoto K, Wajima N, Kawasaki
H, et al: Vimentin expression of esophageal squamous cell carcinoma
and its aggressive potential for lymph node metastasis. Biomed Res.
31:105–112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ando N, Iizuka T, Ide H, Ishida K, Shinoda
M, Nishimaki T, Takiyama W, Watanabe H, Isono K, Aoyama N, et al:
Surgery plus chemotherapy compared with surgery alone for localized
squamous cell carcinoma of the thoracic esophagus: A Japan Clinical
Oncology Group Study-JCOG9204. J Clin Oncol. 21:4592–4596. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ando N, Kato H, Igaki H, Shinoda M, Ozawa
S, Shimizu H, Nakamura T, Yabusaki H, Aoyama N, Kurita A, et al: A
randomized trial comparing postoperative adjuvant chemotherapy with
cisplatin and 5-fluorouracil versus preoperative chemotherapy for
localized advanced squamous cell carcinoma of the thoracic
esophagus (JCOG9907). Ann Surg Oncol. 19:68–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yokota T, Ando N, Igaki H, Shinoda M, Kato
K, MIzusawa J, Katayama H, Nakamura K, Fukuda H and Kitagawa Y:
Prognostic factors in patients receiving neoadjuvant 5-fluorouracil
plus cisplatin for advanced esophageal cancer (JCOG9907). Oncology.
89:143–151. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jamieson CH, Ailles LE, Dylla SJ,
Muijtjens M, Jones C, Zehnder JL, Gotlib J, Li K, Manz MG, Keating
A, et al: Granulocyte-macrophage progenitors as candidate leukemic
stem cells in blast-crisis CML. N Engl J Med. 351:657–667. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang W, Yan HX, Chen L, Liu Q, He YQ, Yu
LX, Zhang SH, Huang DD, Tang L, Kong XN, et al: Wnt/beta-catenin
signaling contributes to activation of normal and tumorigenic liver
progenitor cells. Cancer Res. 68:4287–4295. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Noda T, Nagano H, Takemasa I, Yoshioka S,
Murakami M, Wada H, Kobayashi S, Marubashi S, Takeda Y, Dono K, et
al: Activation of Wnt/beta-catenin signaling pathway induces
chemoresistance to interferon-alpha/5-fluorouracil combination
therapy for hepatocellular carcinoma. Bri J Cancer. 100:1647–1658.
2009. View Article : Google Scholar
|
